Koebnerization of acquired reactive perforating collagenosis after wet cupping successfully treated with UVA1 phototherapy

2020 ◽  
Vol 33 (6) ◽  
Author(s):  
Tugba Kevser Uzuncakmak ◽  
Filiz Cebeci Kahraman ◽  
Zeynep Arslan ◽  
Mehmet Salih Gürel ◽  
Bengu Cobanoglu Simsek
Keyword(s):  
Uva1 Phototherapy ◽  
Reactive Perforating Collagenosis

Reactive Perforating Collagenosis

1979 ◽  
Vol 41 (1) ◽  
pp. 41-45 ◽  
Author(s):  
Hiroshi MACHINO ◽  
Tomoyuki KAWATSU ◽  
Yoshiharu MIKI
Keyword(s):  
Reactive Perforating Collagenosis

scholarly journals Necrotic plaques in an elderly male

JRSM Open ◽  
2021 ◽  
Vol 12 (2) ◽  
pp. 205427042098145
Author(s):  
Bindi Gaglani ◽  
Ian Logan ◽  
Faris Kubba
Keyword(s):  
Diabetes Mellitus ◽  
Genetic Predisposition ◽  
Unusual Case ◽  
Renal Diseases ◽  
Elderly Male ◽  
Unusual Form ◽  
Underlying Diseases ◽  
Reactive Perforating Collagenosis ◽  
Giant Form

Reactive perforating collagenosis is commonly recognised as an unusual form of transepithelial elimination of collagen and elastin fibres which are extruded through the epidermis in patients with a genetic predisposition or underlying diseases, such as diabetes mellitus or renal diseases. We present the unusual case of an 87-year-old diabetic male with a giant form of reactive perforating collagenosis and review the available literature.

scholarly journals Successful treatment of acquired reactive perforating collagenosis with itraconazole

2021 ◽  
Vol 26 (1) ◽  
Author(s):  
Binrong Ye ◽  
Yi Cao ◽  
Yeqiang Liu
Keyword(s):  
Skin Biopsy ◽  
Fungal Infection ◽  
Successful Treatment ◽  
Rare Form ◽  
Case Presentation ◽  
Therapeutic Benefits ◽  
Immunological Tests ◽  
Anti Inflammatory ◽  
Reactive Perforating Collagenosis

Abstract Background Acquired reactive perforating collagenosis (ARPC) is a rare form of transepithelial elimination in which altered collagen is extruded through the epidermis. Case presentation A 23-year-old male presented with cup-like ulcerated lesions on his limbs since 3 months. A series of serological and immunological tests showed no abnormalities. A diagnosis of ARPC was based on skin biopsy findings. The patient was cured using treatment with itraconazole for 8 weeks, in the absence of a fungal infection. Conclusions The anti-inflammatory and anti-angiogenic effects of itraconazole can have good therapeutic benefits for ARPC.

A giant variant of acquired reactive perforating collagenosis

2021 ◽  
Author(s):  
Nao Kusutani ◽  
Sakurako Arai ◽  
Akiko Imanishi ◽  
Naoki Maekawa ◽  
Kazuyoshi Fukai
Keyword(s):  
Reactive Perforating Collagenosis

scholarly journals Granulomatous Slack Skin Responds to UVA1 Phototherapy

Dermatology ◽  
2009 ◽  
Vol 219 (3) ◽  
pp. 268-271 ◽  
Author(s):  
Patrick A. Oberholzer ◽  
Antonio Cozzio ◽  
Reinhard Dummer ◽  
Lars E. French ◽  
Günther F.L. Hofbauer
Keyword(s):  
Uva1 Phototherapy

scholarly journals UVA1 Phototherapy of Netherton Syndrome

2003 ◽  
Vol 84 (1) ◽  
pp. 69-71 ◽  
Author(s):  
Rossana Capezzera ◽  
Marina Venturini ◽  
Denise Bianchi ◽  
Cristina Zane ◽  
Piergiacomo Calzavara-Pinton
Keyword(s):  
Netherton Syndrome ◽  
Uva1 Phototherapy

Reactive perforating collagenosis

1985 ◽  
Vol 113 (s29) ◽  
pp. 44-45
Author(s):  
E. Young ◽  
F. Wojnarowska ◽  
P. Millard
Keyword(s):  
Reactive Perforating Collagenosis

scholarly journals Reactive perforating collagenosis

2016 ◽  
Vol 7 (2) ◽  
pp. 139 ◽  
Author(s):  
Sandeep Arora ◽  
Ajay Malik ◽  
Anil Balki
Keyword(s):  
Reactive Perforating Collagenosis

scholarly journals Uva1 Phototherapy in the Management of Sclerodermatous Graft-Versus-Host Disease (Gvhd): a report of two cases / Uva1 fototerapija u lečenju sklerodermatoznog oblika hronične Gvhd: Prikaz dva slučaja

2009 ◽  
Vol 1 (4) ◽  
pp. 147-152 ◽  
Author(s):  
Hiva Fassihi ◽  
Kamran Iqbal ◽  
Trish Garibaldinos ◽  
Robert Sarkany ◽  
Julia Scarisbrick ◽  
...  
Keyword(s):  
Graft Versus Host Disease ◽  
Skin Diseases ◽  
Hematopoietic Stem ◽  
Host Disease ◽  
Allogeneic Hsct ◽  
Graft Versus Host ◽  
Uva1 Phototherapy ◽  
Matched Sibling

Abstract Chronic graft-versus-host disease (GVHD) is a frequent complication after allogeneic hematopoietic stem cell transplantation (HSCT). Approximately 10% of patients with GVHD develop sclerodermatous changes, which can cause significant morbidity and are often refractory to standard systemic immunosuppression. We present two cases of sclerodermatous GVHD. The first is a 39-year-old man, who had a matched sibling, undergoing allogeneic HSCT for severe aplastic anemia. The second patient is a 7-year-old boy, who had an allogeneic HSCT from his HLA-identical mother for acute myeloid leukemia (AML). Both patients presented with widespread sclerotic changes, resulting in joint contractures and significant functional difficulties. Studies have shown UVA1 phototherapy to be a promising and well tolerated treatment modality in patients with sclerotic skin diseases. Both of our patients were treated with UVA1, which resulted in a significant skin softening, improvement in joint mobility and quality of life. UVA1 appears to be an effective treatment for refractory sclerodermatous GVHD; however, long-term clinical studies in larger groups are needed to accurately evaluate its efficacy and safety.

Sign in / Sign up

Export Citation Format

Share Document